【前列腺癌】「CDX Prostate」:基於血液診斷「前列腺癌」的風險

 【前列腺癌】「CDX Prostate」:基於血液診斷「前列腺癌」的風險

 文章出處  

Businesswire 

 

 原文標題  

Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States 

 

 Twitter  

https://x.com/aimedadviser/status/1838730915159380178 

 

 文章序號  

6328 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.